Injective ETF on Track: Canary Capital Launches Trust For ‘Staked INJ’ Product

Canary Capital has taken a significant step toward bringing an Injective-based exchange traded fund (ETF) to the US market. The firm recently set up a Delaware trust, the “Canary Staked INJ ETF,” to facilitate the proposed launch of this novel product. This marks a first in the world of crypto ETFs, focusing on both price movements and staking rewards for the INJ token, offering investors unique benefits not available in traditional investment vehicles.